CompletedNCT04785105Updated Mar 5, 2021

Natural History of Asymptomatic Superior Mesenteric Arterial Stenosis.

An observational study in Stenosis, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2021-03-05.

Sponsored by Hospices Civils de Lyon · Observational

Study type: Observational
Model: Cohort
Time perspective: Retrospective
Enrollment: 77
Sex: All

Study summary

The aim of this study was to evaluate asymptomatic superior mesenteric artery (SMA) stenosis prognosis according to the presence of coeliac artery (CA) and/or inferior mesenteric artery (IMA) associated stenosis.

Read the detailed description

BACKGROUND: The benefit of preventive treatment for SMA stenosis remains uncertain. The latest guidelines remain unclear given the lack of data in the literature.

Conditions studied

Stenosis

Browse trials for

Constriction, Pathologic 1,117

Keywords

SMA
Stenosis
Stenosis on scanner

In context

Constriction, Pathologic

1,117 studies on the registry are indexed under Constriction, Pathologic; 231 are open to participants now.

This study's enrollment of 77 is below the median of 121 across 390 observational studies indexed under Constriction, Pathologic.

Browse Constriction, Pathologic studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

patients with isolated >70% SMA stenosis
patients with both SMA stenosis and CA or/and IMA >70% stenosis

Inclusion criteria

the presence of coeliac artery (CA) and/or inferior mesenteric artery (IMA) associated stenosis.

Exclusion criteria

Exclusion Criteria:

Study design

Observational model: Cohort
Time perspective: Retrospective
Enrollment: 77 participants (actual)
Patient registry: No

Groups and cohorts

patient with isolated SMA stenosis
patient with isolated SMA stenosis on initial scanner
Other: No intervention
patient with both SMA stenosis and CA or/and IMA stenosis
patient with both SMA stenosis and CA or/and IMA stenosis on initial scanner
Other: No intervention

Interventions

OtherNo intervention
No intervention

What researchers measure

Primary outcomes

Development of mesenteric disease defined as acute mesenteric ischemia or chronic mesenteric ischemia.
Time frame: 4 years

Study locations

1 site

Groupement Hospitalier Est
Bron, 69500, France

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Mar 5, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT04785105
Lead sponsor: Hospices Civils de Lyon
Responsible party: Sponsor
First posted: Mar 5, 2021
Start date: Feb 1, 2017
Primary completion: Dec 1, 2019
Completion: Mar 1, 2020
Last update: Mar 5, 2021

Oversight

FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Constriction, Pathologic→

Other studies from this sponsor

Hospices Civils de Lyon

Start the discussion